1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.
160.90 -0.79 (-0.49%)
15,564
XNAS Volume

XNAS 16 Jan, 2026 9:39 AM (EST)

Watchlist

Portfolio

Alert

Repligen Corp - RGEN - stock price prediction, stock price target, analyst ratings from 21 analysts

Repligen Corp has a share price target of US$ 190, revenue growth forecast of 15.6%, and profit growth estimate of 287.2% for FY25, based on top 21 analyst calls.